End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
01 1ALLEGRA
02 3ATOVAQUONE
03 1CARBAMAZEPINE
04 1CHILDRENS ADVIL
05 1CHILDRENS ADVIL-FLAVORED
06 1CHILDRENS ALLEGRA ALLERGY
07 1CHILDRENS ALLEGRA HIVES
08 1CHILDRENS FEXOFENADINE HYDROCHLORIDE ALLERGY
09 1CHILDRENS FEXOFENADINE HYDROCHLORIDE HIVES
10 1CHILDRENS IBUPROFEN
11 1CHILDRENS MOTRIN
12 8CLOBAZAM
13 7IBUPROFEN
14 1KIONEX
15 1MEGACE
16 1MEGESTROL ACETATE
17 1MEPRON
18 1NYSTATIN
19 1OXCARBAZEPINE
20 1SODIUM POLYSTYRENE SULFONATE
21 1TERIL
22 1VERSACLOZ
01 120264
02 120500
03 120516
04 220589
05 121963
06 140028
07 162876
08 174916
09 174937
10 174978
11 175671
12 175714
13 176729
14 176925
15 190590
16 2201373
17 1202961
18 2203330
19 1203479
20 1205647
21 1208819
22 1209105
23 1209179
24 1209204
25 1209207
26 1209685
27 1209715
28 1210039
29 1210546
30 1210569
31 1210692
32 1210746
33 1211259
34 1213110
01 34No
02 3Yes
End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.
Drug : VERSACLOZ
Dosage Form : SUSPENSION; ORAL
Application Number : 203479
Country : US
Patented : Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : MEGESTROL ACETATE
Dosage Form : SUSPENSION; ORAL
Application Number : 75671
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 208819
Country : US
Patented : No
Drug : MEGACE
Dosage Form : SUSPENSION; ORAL
Application Number : 20264
Country : US
Patented : No
Drug : ATOVAQUONE
Dosage Form : SUSPENSION; ORAL
Application Number : 209685
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 205647
Country : US
Patented : No
Drug : CLOBAZAM
Dosage Form : SUSPENSION; ORAL
Application Number : 211259
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 209207
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : IBUPROFEN
Dosage Form : SUSPENSION; ORAL
Application Number : 209204
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Drug : CHILDRENS MOTRIN
Dosage Form : SUSPENSION; ORAL
Application Number : 20516
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
